Blog
RSS FeedPosted by Michael Wonder on 08 Jun 2022
EMA adopts first list of critical medicines for COVID-19
8 June 2022 - On 7 June 2022, the EMA’s Medicines Shortages Steering Group adopted the list of critical medicines for ...
Posted by Michael Wonder on 02 Jun 2022
COVID-19 vaccine weekly safety report (2 June 2022)
2 June 2022 - To 29 May 2022, the TGA has received 573 reports which have been assessed as likely to ...
Posted by Michael Wonder on 29 May 2022
ATAGI update following weekly COVID-19 meeting (25 May 2022)
27 May 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 25 ...
Posted by Michael Wonder on 26 May 2022
COVID-19 vaccine weekly safety report (26 May 2022)
26 May 2022 - To 22 May 2022, the TGA has received 555 reports which have been assessed as likely to ...
Posted by Michael Wonder on 25 May 2022
Expanded ATAGI recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19
25 May 2022 - The Australian Technical Advisory Group on Immunisation (ATAGI) have expanded their recommendations on the use of additional ...
Posted by Michael Wonder on 23 May 2022
ATAGI update following weekly COVID-19 meeting (18 May 2022)
23 May 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 18 ...
Posted by Michael Wonder on 19 May 2022
COVID-19 vaccine weekly safety report (19 May 2022)
19 May 2022 - To 15 May 2022, the TGA has received 555 reports which have been assessed as likely to ...
Posted by Michael Wonder on 17 May 2022
International regulators and WHO: support health care professionals to enhance public confidence in COVID-19 vaccines
17 May 2022 - the EMA has endorsed a statement for health care professionals jointly developed by the International Coalition ...
Posted by Michael Wonder on 13 May 2022
TGA removes age limit for BBIBP-CorV (Sinopharm) COVID-19 vaccine recognition for international travel to Australia
13 May 2022 - The TGA has determined that the BBIBP-CorV (Sinopharm) COVID-19 vaccine will be 'recognised' for all ages for ...
Posted by Michael Wonder on 12 May 2022
ATAGI update following weekly COVID-19 meeting (11 May 2022)
12 May 2022 - On Wednesday 11 May 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. ...
Posted by Michael Wonder on 12 May 2022
COVID-19 vaccine weekly safety report (12 May 2022)
12 May 2022 - To 8 May 2022, the TGA has received 554 reports which have been assessed as likely to ...
Posted by Michael Wonder on 11 May 2022
ATAGI update following weekly COVID-19 meeting (4 May 2022)
9 May 2022 - On Wednesday 4 May 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. ...
Posted by Michael Wonder on 05 May 2022
COVID-19 vaccine weekly safety report (5 May 2022)
5 May 2022 - To 1 May 2022, the TGA has received 546 reports which have been assessed as likely to ...
Posted by Michael Wonder on 28 Apr 2022
COVID-19 vaccine weekly safety report (28 April 2022)
28 April 2022 - To 24 April 2022, the TGA has received 544 reports which have been assessed as likely to ...
Posted by Michael Wonder on 21 Apr 2022
COVID-19 vaccine weekly safety report (24 April 2022)
24 April 2022 - To 17 April 2022, the TGA has received 534 reports which have been assessed as likely to ...